Jane Street’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.45M Buy
2,007,571
+1,886,481
+1,558% +$3.24M ﹤0.01% 1645
2025
Q1
$403K Sell
121,090
-174,138
-59% -$580K ﹤0.01% 4194
2024
Q4
$2.18M Buy
295,228
+178,258
+152% +$1.32M ﹤0.01% 2000
2024
Q3
$1.1M Sell
116,970
-913,342
-89% -$8.58M ﹤0.01% 3259
2024
Q2
$8.26M Buy
1,030,312
+9,245
+0.9% +$74.1K ﹤0.01% 1197
2024
Q1
$15.1M Buy
1,021,067
+498,506
+95% +$7.39M ﹤0.01% 614
2023
Q4
$4.25M Sell
522,561
-27,354
-5% -$222K ﹤0.01% 1655
2023
Q3
$2.5M Buy
549,915
+147,598
+37% +$672K ﹤0.01% 1985
2023
Q2
$2.83M Buy
402,317
+336,633
+513% +$2.37M ﹤0.01% 2048
2023
Q1
$401K Sell
65,684
-36,235
-36% -$221K ﹤0.01% 3916
2022
Q4
$651K Buy
101,919
+41,101
+68% +$263K ﹤0.01% 3100
2022
Q3
$583K Sell
60,818
-69,299
-53% -$664K ﹤0.01% 3415
2022
Q2
$1.44M Sell
130,117
-181,203
-58% -$2M ﹤0.01% 2368
2022
Q1
$5.18M Buy
311,320
+141,703
+84% +$2.36M ﹤0.01% 1165
2021
Q4
$3.24M Buy
169,617
+57,383
+51% +$1.1M ﹤0.01% 1421
2021
Q3
$2.77M Sell
112,234
-19,762
-15% -$487K ﹤0.01% 1492
2021
Q2
$3.43M Buy
131,996
+48,609
+58% +$1.26M ﹤0.01% 1244
2021
Q1
$2.64M Sell
83,387
-19,750
-19% -$625K ﹤0.01% 1359
2020
Q4
$4.79M Sell
103,137
-70,371
-41% -$3.27M ﹤0.01% 756
2020
Q3
$5.71M Sell
173,508
-216,990
-56% -$7.14M ﹤0.01% 545
2020
Q2
$10.7M Buy
390,498
+327,885
+524% +$9M 0.01% 373
2020
Q1
$1.87M Buy
62,613
+33,358
+114% +$998K ﹤0.01% 1081
2019
Q4
$810K Sell
29,255
-3,727
-11% -$103K ﹤0.01% 1781
2019
Q3
$600K Sell
32,982
-9,742
-23% -$177K ﹤0.01% 2027
2019
Q2
$1.05M Buy
+42,724
New +$1.05M ﹤0.01% 1582
2017
Q4
Sell
-21,204
Closed -$164K 3264
2017
Q3
$164K Buy
+21,204
New +$164K ﹤0.01% 2664